Novacyt Akcija

Novacyt Goodwill

Vrijednost Goodwill (Reputacijska vrednost) od Novacyt (ALNOV.PA) na dan 21. авг 2026. je 2,67 М GBP. Prethodne godine, Goodwill (Reputacijska vrednost) je bio 21,45 М GBP — promjena od -87,55% (niži).

Goodwill

2,67 МGBP

YoY

-87,55%

Zadnja ažuriranja:

Goodwill (Reputacijska vrednost) od Novacyt je 2026 2,67 М GBP. Goodwill (Reputacijska vrednost) od Novacyt je bio 2025 21,45 М GBP. Pad je time -87,55% niži u odnosu na prethodnu godinu.
Access this data via the Eulerpool API

Novacyt Анализа акција

Šta radi Novacyt? Novacyt SA is a leading biotechnology company specializing in the development and marketing of diagnostic products and technologies. The company was founded in 2006 and has experienced impressive growth since then. Its headquarters are located in Paris. Novacyt's business model revolves around the development and marketing of diagnostic products and technologies, particularly molecular diagnostic kits and reagents used for identification and quantification of microorganisms, viruses, and genetic differences. These products are commonly used in medical research, clinical diagnostics, and environmental analysis. Novacyt is divided into several divisions, each offering different products and services. Its diagnostic business specializes in the research, development, and marketing of molecular diagnostic kits, including the Primerdesign Kits specifically designed for COVID-19 identification. The company also provides laboratory and service offerings, such as DNA sequencing, qPCR analysis, sample preparation, and PCR disinfection. Additionally, Novacyt offers various diagnostic tests capable of detecting genetic differences and mutations. Its PathFlow division focuses on improving the process from diagnosis to therapy and follow-up, particularly for oncology patients. In response to the COVID-19 pandemic, Novacyt quickly launched a PCR test kit for COVID-19, which has been approved in numerous countries worldwide. Novacyt has successfully established itself as a key player in the fight against the pandemic. In summary, Novacyt SA is a leading biotechnology company specializing in the development and marketing of diagnostic products and technologies. Through its divisions, the company ensures the optimal utilization of molecular diagnostic tests. Novacyt has become an important player in the fight against the pandemic through its rapid response and development of molecular diagnostic kits for COVID-19, establishing itself as a reliable and innovative partner for medical research and clinical diagnostics. Novacyt je jedna od najpopularnijih kompanija na Eulerpool.

Često postavljena pitanja o akciji Novacyt

Goodwill (Reputacijska vrednost) kompanije Novacyt iznosi 2,67 М GBP u 2026. godini.

Goodwill (Reputacijska vrednost) od Novacyt se promijenio sa 21,45 М GBP na 2,67 М GBP, što predstavlja promjenu od -87,55%. Vrijednost je niži nego prethodne godine.

Na Eulerpool-u možete pronaći potpuni historijski razvoj Goodwill (Reputacijska vrednost) Novacyt od 2006. — sa godišnjim vrijednostima, grafikonima i detaljnom analizom.

Goodwill je premija plaćena iznad fer vrednosti na tržištu u akviziciji. Predstavlja neopipljivu vrednost kao što su prepoznavanje brenda, odnosi sa kupcima i intelektualna svojina.

Goodwill (Reputacijska vrednost)'s GBP je ključan faktor za investitore. Promene u ovoj metrici mogu signalizirati poboljšane ili pogoršane fundamentalne faktore, direktno utiču na cenu akcije. Na Eulopoolu, možete pratiti Goodwill (Reputacijska vrednost)'s Novacyt istorijski i u realnom vremenu.

Access this data via the Eulerpool API

Билансни лист — Novacyt

Sve ključne metrike — Novacyt

Раст